Table 2.
Effect of A. nilotica extracts on lipid profile in the experimental rats.
| TG (mg/dL) | TC (mg/dL) | LDL-C (mg/dL) | HDL-C (mg/dL) | |
|---|---|---|---|---|
| Normal | 99 ± 11 | 144 ± 22 | 79 ± 14 | 45 ± 6 |
| HFD Control | 171 ± 32∗ | 210 ± 34∗ | 149 ± 19∗ | 27 ± 9∗ |
| Orlistat | 112 ± 14# | 172 ± 28∗# | 114 ± 19∗# | 36 ± 6∗# |
| Total (250 mg/kg) | 155 ± 24∗ˆ | 190 ± 30∗ | 131 ± 15∗ˆ | 28 ± 10∗ˆ |
| Total (500 mg/kg) | 151 ± 21∗#ˆ | 182 ± 28∗ | 123 ± 14∗# | 29 ± 10∗ˆ |
| EA (250 mg/kg) | 120 ± 12∗# | 167 ± 18∗# | 104 ± 8∗# | 39 ± 8∗# |
| EA (500 mg/kg) | 118 ± 12∗# | 165 ± 13∗# | 101 ± 7∗# | 40 ± 8# |
| Bu (250 mg/kg) | 150 ± 22∗#ˆ | 183 ± 25∗ | 122 ± 16∗# | 31 ± 5∗ |
| Bu (500 mg/kg) | 143 ± 17∗#ˆ | 179 ± 18∗# | 120 ± 9∗# | 30 ± 6∗ |
EA, ethyl acetate fraction; Bu, butanol fraction; TG, triglycerides; TC, total cholesterol; LDL-C, low density lipoprotein-cholesterol, HDL-C, high density lipoprotein-cholesterol. Data are represented as mean ± SD and analyzed by ANOVA followed by Tuckey's post hoc test. ∗ significantly different compared to the normal group; # significantly different compared to the HFD control group; ˆ significantly different compared to the orlistat treated group. Differences were considered significantly different at P < 0.05.